Bariatrics Surgery 2023 | Berlin | Germany | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Bariatrics Surgery

- Bariatrics Surgery 2023

Welcome Message

Bariatric surgery 2023 has the pleasure to welcome all bariatric researchers, doctors, surgeons, professors, students, and experts from all over the globe to take part in the most awaited international conference on the "international conference on Clinical Gastroenterology bariatric surgery" which will be going to be held on March 02-04,2023 in Zurich, Switzerland Gastroenterology

Bariatric surgery 2023 removes the barriers of travel and uncertainty to share the most recent scientific advances and innovations in obesity management and bariatric surgery. Undoubtedly, the conference will come up with a lot of unknown knowledge that should be known by the world.

This global event will cover some of the major advancements in bariatric surgery and oobesity management it will ensure to take a new step toward a better future.

Bariatric surgery 2023 aims to present and discuss innovations, trends, concerns, practical difficulties encountered, and solutions for Bariatric Surgery on an exclusive platform for new researchers, scholars, and educators. This medical accumulation ensures that imparting the mind and thoughts will allow and steady you in the theme "Approach the future of Gastroenterology bariatric surgery ".

Bariatric surgery 2023 includes oral lectures, keynote forums, and poster presentations. And The research community will gain much from attending the congress, exchanging knowledge, and cooperating. Simultaneously, the conference will be an exceptional opportunity to imbibe the most recent insights and trends related to obesity and bariatric surgery and its implications, meet, mingle, and network with the who's who in the field, and nurture the endeavor for successfully dealing with the current bariatric surgery epidemic and its consequences.

We hope to see you in Zurich and look forward to sharing new information and exciting discoveries with you.

Regards

Program manager | bariatric surgery 2023

Sessions & Tracks

Track 1: Bariatric surgery

Obesity is more than just a chronic disease; it is a persistent, complex disease caused by a metabolic malfunction. It is a complex illness process that requires ongoing research and several medications to be controlled. Attempts have been made to distinguish between bariatric surgery and metabolic surgery, however current data and opinion support the use of the term bariatric metabolic surgery to appropriately represent these surgical approaches.

bariatric surgery is recent surgery for weight loss surgery. Various phrases are used to indicate the influence of these surgeries on patients' weight and metabolism health (breakdown of food into energy). Aside from treating obesity, these procedures are also quite helpful in treating diabetes, high blood pressure, sleep apnea, and high cholesterol, among many other ailments. These surgeries can also help to avoid future health issues. The advantages allow people with obesity who choose to receive treatment to have a higher quality of life as well as a longer and healthier lifespan. Gastric bypass, sleeve gastrectomy, gastric band, and duodenal switch are all bariatric surgical treatments. These procedures are effective in treating class iii obesity. They also aid in the normalization of your metabolism, including blood sugar, blood pressure, and cholesterol levels.

Biliopancreatic diversion with duodenal switch

Sleeve gastrectomy
Roux-en-Y
Endoscopic Bariatric Therapies
Complications of bariatric surgery

Related conference:

Related associations &societies:

Track 2: Obesity

The fact that the obesity pandemic did not sweep across countries like wildfire, but rather smolder and then steadily grow year after year, has made it even more difficult to tackle since its causes have become so ingrained in the social, environmental, and governmental fabric. It has an impact on both developing and developed countries. Diet, physical activity, mechanization, urbanization, genetic predisposition, drugs, mental problems, economic policies, endocrine diseases, and exposure to endocrine-disrupting chemicals are some of the recognized factors. Furthermore, research has indicated that consuming ultra-processed foods increases the risk of obesity, diabetes, and cardiovascular disease. Dependable sources this has resulted in the establishment of an alternate public health policy that stresses restricting ultra-processed foods rather than nutritional consumption.

Obesity appears to increase the risk of many other serious chronic diseases, as well as the risk of severe illness from covid-19. Everyone can help to reverse the trend of obesity and its disproportionate impact on racial and ethnic minority groups.

Covid-19 and obesity
Morbid obesity
Postpartum obesity
Single-gene obesity

Related conference:

Related associations &societies:

Track 3: Gastroenterology

The focus of the medical speciality of gastroenterology is the digestive system and related issues. This field of study focuses on conditions affecting the gastrointestinal system, which encompasses the alimentary canal as well as organs from the mouth to the anus. Gastroenterologists are medical professionals with a focus in this area. The focus of the medical speciality of gastroenterology is the digestive system and related issues. This field of study focuses on conditions affecting the gastrointestinal system, which encompasses the alimentary canal as well as organs from the mouth to the anus. Gastroenterologists are medical professionals with a focus in this area.

Gastroenterology
gastroenterology Surgery
Esophageal Disorder
Inflammatory Bowl disease

Related conference:

Related associations &societies:

Track 4: Obesity in women

Obesity and overweight pose significant public health threats as a rising epidemic in many countries. 1 in recent years, an increase in body mass index (BMI) has been linked to an increase in the risk burden of noncommunicable chronic diseases globally.

Obesity and overweight are well-known risk factors for a wide range of non-communicable diseases. Evidence suggests that the burden of overweight and obesity is increasing in low and middle-income countries, particularly among women.

Adiposity has specific implications for women's reproductive health. Obesity in women is associated with changes in the reproductive cycle, resulting in lower fertility, as well as an increased risk of the polycystic ovarian syndrome and sporadic or no ovulation. Overweight women with pros are predisposed to insulin resistance and are more likely to develop diabetes in the future. All of these problems make infertility therapy more difficult and less effective. Furthermore, the tendency toward menstruation and ovarian diseases associated with obesity may lead to an increased risk of ovarian, endometrial, and breast cancer. It is now evident that the prevalence of all gynecological cancers increases with BMI.

Women's Health
Pediatric and adolescent gynecology
Candy cane syndrome
Chronic diseases

Related conferences

Related associations &societies:

Track 5: Endocrinal and hormonal obesity

Endocrinology is a field of biology and medicine that focuses on the endocrine system, disorders that affect it, and the particular hormone releases that, when out of balance, lead to obesity. The integration of developmental processes like proliferation, growth, and differentiation as well as psychological and behavioral processes like metabolism, growth, and development, tissue function, sleep, digestion, respiration, excretion, mood, and sensory perception brought on by hormones are also taken into consideration. Hormonal imbalance is a result of eating disorders. A neurosecretory neuron releases a "classical" hormone called a neuroendocrine signal into the blood. Chemicals known as endocrine disruptors have the potential to interact with the body's endocrine system

Obesity and growth hormone
Obesity and sex hormones
Leptin and insulin
Hypothalamic-pituitary hormones axes

Recent conferences

Related associations &societies:

Track 6: Bariatric surgery vs. Liposuction

Both bariatric surgery and liposuction are procedures that aim to reduce excess body weight. However, each of these is a distinct type of surgery. Bariatric procedures are being performed at an alarmingly high rate across the world. Intensive scientific activity in this field has been observed in recent years. Today's metabolic and bariatric operations have been refined over many decades and are among the most thoroughly researched treatments in modern medicine. They are carried out using short incisions and with minimally invasive surgical procedures (laparoscopic and robotic surgery). These developments allow patients to have a better overall experience with less pain, fewer problems, shorter hospital stays, and faster recovery.

liposuction is a well-known and widely utilized surgical treatment for reducing localized levels of adipose tissue in specific areas of the body. Since its debut, liposuction has been enhanced and has found extensive use, notably in cosmetic operations. This exercise will cover liposuction methods and highlight the role of the interprofessional team in evaluating and treating liposuction patients.

VASER
Temporary inch loss
Hematoma and liposuction

Recent conferences:

Related associations &societies:

Track 7: Pelvic surgery

In pelvic surgery, a variety of methods and procedures are used, depending on the particular disease and the underlying reason. To choose the best method for the repair, it is crucial to identify the precise defect.

Treatment options for pelvic organ prolapse include abdominal or vaginal methods. Colporrhaphy and fixation of the vagina to the sacral ligaments are two procedures done via the vaginal channel. Colporrhaphy involves plication of the muscle layer, which reduces the size of the vaginal canal. The abdominal method, on the other hand, enables pelvic reconstruction, including Sacro colpopexy, in which a graft is used to support the vagina. The abdominal approach can now be carried out laparoscopically, allowing for a less invasive method of doing the treatment.

Colpocleisis, which entails the removal of the vaginal epithelium and closure of the vagina, may be necessary in some individuals, particularly those who are poor surgical candidates. In order to assist closure and stop urine leakage, surgical management of urinary incontinence aims to partially restrict the urethra. Retropubic suspension, the Burch technique, and the Marchall-Marchetti-Krantz treatment are just a few of the procedures that might be used to accomplish this objective. Pelvic operations for incontinence may also entail the implantation of artificial sphincters or the making of slings.

Obliterative surgery
R econstructive surgery

Related conference:

Related associations &societies:

Track 8: Nutrition

Over the past two to three decades, there has been a marked rise in the prevalence of overweight and obesity across all age categories. An excessive buildup of fat in various areas of the body is caused by a disparity between energy consumption and energy output.

To control obesity in people, nutrition plays a significant role. A nutritious diet must be consumed to reduce obesity. Several foods burn fat that should be consumed to combat obesity. This indicates that obese people should pay special attention to their diets.

Bariatric surgery is an effective treatment option for obesity that has gained widespread acceptance among patients in recent years. Obese people's poor nutritional habits, despite their high caloric intake, result in a deficiency of several vitamins, minerals, and trace elements required for body metabolism and normal physiological processes.

the recent bariatric surgical approaches can cause nutrient absorption differently and some nutritional deficiencies. To avoid the adverse effects of vitamin and trace element insufficiency, proper monitoring, tests, and some supplementation treatments are recommended

Nutritional Immunology
Food and Nutrition Policies
Overnutrition
Nutrigenomics
Nutritional Toxicities
Prenatal nutrition
Supplementation treatments after bariatric surgery

Related conference:

Related associations &societies:

Track 9: Colorectal and Intestinal Disorders

The removal of the epithelium and closure of the vagina may be necessary in some individuals, particularly those who are poor surgical candidates. This procedure is known as colpocleisis. In order to assist closure and stop urine leakage, surgical management of urinary incontinence aims to partially restrict the urethra. Retropubic suspension, the Burch technique, and the Marchall-Marchetti-Krantz treatment are just a few of the procedures that might be used to accomplish this objective. Pelvic operations for incontinence may also entail the implantation of artificial sphincters or the making of slings.

Related conference:

Associations &societies:

Track 10: Anti-obesity drugs

Weight loss pharmaceuticals and anti-obesity medications are pharmacological agents that reduce or control weight. These medications modify one of the major processes of the human body or weight regulation by altering either appetite or calorie absorption. Dieting and physical exercise remain treatment modalities for overweight and obese individuals. Because the human body utilizes many chemicals and hormones to protect its stores of fat reaction, it was probably advantageous to our ancestors when food was scarce in the past. The mechanisms that control energy balance have significant built-in redundancy, overlap with other physi?l?gi??l functions, and are influenced by social, hedonic, and psychological factors that restrict the efficacy of Ph?rm???l?gi??l interventions.

According to a new study, a drug called semaglutide, which is licensed for adults who are obese or overweight, can also help adolescents lose weight and have healthier hearts.

Semaglutide (hormone-based obesity medications)
Pharmacological agents
Anti-aging strategies
Naltrexone/bupropion
Side effects of anti-obesity drugs
Neuroendocrine consideration

Related conference:

Related associations &societies:

Track 11: Gastroesophageal refluxes

Research that examined the impact of bariatric surgery on Gerd although weight reduction and lifestyle changes are beneficial in lowering Gerd symptoms, different bariatric operations yield variable degrees of symptom relief. ROUX-EN-Y gastric bypass seems to be the most effective treatment for Gerd

However laparoscopic sleeve gastrectomy appeared to substantially increase illness incidence. Adjustable gastric banding was found to initially relieve GERD symptoms; nevertheless, during long-term follow-up, a subset of patients developed a new start of GERD symptoms. According to the research, different procedures have varying effects on the symptomatology of GERD, and thorough evaluation may be required before undergoing bariatric surgery in GERD patients.

Impact of bariatric surgery on GERD
Gerd symptoms ROUX-EN-Y
gastric bypass surgery

Related conference:

Related associations &societies:

Track 12: Single-incision laparoscopic surgery (Sils)

The novel port entrance method known as single incision laparoscopic surgery is one of the most recent advancements in bariatric surgery. Sils is the next generation of laparoscopy, with access via a single port rather than numerous ports. Because it will be buried inside the belly button, the surgery will be scarless thanks to the use of new specialist ports and articulator devices. Although this process takes longer, it provides earlier post-operative recovery with less discomfort than standard laparoscopy, making it a therapy of choice for patients.

- Laparoscopic surgery for colorectal cancer
- Sils for infants and children
- Appendicectomy; colectomy; cholecystectomy
- Safety and feasibility

Related conference:

Related associations &societies:

Track 13: Laparoscopic duodenojejunal bypass with sleeve gastrectomy

Duodenojejunal bypass (DJB) is a revolutionary metabolic operation based on the foregut theory. According to reports, DJB is a stand-alone therapy for treating diabetes in non-obese people. DJB is paired with sleeve gastrectomy in obese patients. With certain benefits, this combination of DJB and sleeve gastrectomy is offered as an appropriate alternative to ROUX-EN-Y gastric bypass (RYGB).

Additionally, it is predicted to have a potent anti-diabetic impact. Furthermore, retaining the pylorus, a physiological valve, reduces the likelihood of dumping syndrome and anastomotic stenosis, which are frequently troublesome following the gold standard laparoscopic ROUX-EN-Y gastric bypass (LRYGB). Research is now underway to investigate the clinical effects of LSG-DJB on obese individuals with type 2 diabetes mellitus (t2dm)

Duodenojejunal bypass
Anti-diabetic impact
Type 2 diabetes

Related conference:

Balanced Diet And Nutrition Conference | Food Technology And Nutrition Conference 2023 | Obesity Conference 2023 | Bariatric Surgery Conference 2023 | Nutrition Conference 2023 | Obesity And Bariatric Surgery Conference 2023 | Food And Obesity Conference |Food Technology And Obesity Conference | Gastric Bypass And Obesity Conference |Balanced Diet And Obesity Conference Nutritional Genomics Bariatric Surgery Conference | Molecular And Genetic Base Of Bariatric Surgery Conference | Nutrition And Obesity Conference| World Summit On Bariatric Surgery Conference | Gastroenterology In Bariatric Surgery Conference | World Childhood Obesity Management Conference | World Summit On Bariatric Surgery Conference | Gastroenterology In Bariatric Surgery Conference | Advancement In Gastrointestinal And Bariatric Surgery Conference | Nutrition And Weight Management Conference

Related associations &societies:

European Childhood Obesity Group| Global Alliance For The Prevention Of Obesity And Related Chronic Disease | Fresno Metabolic And Bariatric Surgery Program | Bariatric Society| Obesity Medicine Association | European Association For The Study Of Obesity | World Childhood Obesity Management Conference |Asia-Pacific Metabolic And Bariatric Surgery Society | British Association For Parenteral And Enteral Nutrition| Weight Matters |World Obesity Management Association | International Federation For The Surgery Of Obesity And Metabolic Disorders | Latin American Federation Of Societies Of Obesity| Nutrition, And Weight Manage Conference | World Childhood Obesity Management |

Track 14: Stapler malfunctions in bariatric surgery

Staple line leaks are a significant source of morbidity and death in bariatric surgery. For decades, surgical staplers have been used to split and approximate tissue. Overall, surgical staplers have relatively low failure rates, but occurrences might include failure to sepsis, bleeding, locked handles, and other issues. Many skilled surgeons have had similar experiences in their careers. Patients may eventually pay the price for these flaws in the form of significant problems like bleeding or leakage.

- Staple line leaks
- Anastomoses
- Laparoscopic stapling devices
- Polymeric material

Recent conferences

Balanced Diet And Nutrition Conference | Food Technology And Nutrition Conference 2023 | Obesity Conference 2023 |Bariatric Surgery Conference 2023 | Nutrition Conference 2023| Obesity And Bariatric Surgery Conference 2023 | Food And Obesity Conference |Food Technology And Obesity Conference |Gastric Bypass And Obesity Conference | Balanced Diet And Obesity Conference | Risk Factors In Obesity And Bariatric Surgery Conference | World Childhood Obesity Management Conference| Neuroendocrinology And Bariatric Surgery Conference | Genetic Obesity And Bariatric Surgery Conference | Neuroendocrinology And Bariatric Surgery Conference | International Bariatric Surgery Conference Balanced Diet And Obesity Management Conference | Genetic Obesity And Balanced Diet Conference | Genetic Obesity Conference 2023 | Genetic Obesity Conference 2023 | Genetic Obesity Conference | Balanced Diet And Genetic Obesity Conference | Childhood Obesity And Gastric Bypass Conference |

Associations &societies:

Track: 15 Ai in bariatric surgery

The implementation of artificial intelligence technology is expanding in a variety of healthcare sectors. Machine learning methods are being investigated at all stages of the therapeutic route, from pre-surgical risk assessment and intraoperative management through complications and outcome prediction. In light of the rapid expansion of ai implementation, it is critical to understand how these technologies might be leveraged to provide safer, more practical, and cost-effective care.

Ai has contributed to substantial progress in decision-making, quality of care, and precision medicine, but several legal and ethical issues need to be addressed before its widespread application in clinical practice. For the uninitiated physician, ai should be viewed as a revolutionary statistical instrument that, unlike traditional statistics, derives its source material from real-world databases and registries rather than idealized cohorts of patients and is capable of processing massive volumes of data. In this sense, ai is intended to aid decision-making rather than replace critical thinking or surgical skill development. As with any new technology, the therapeutic utility of ai must be demonstrated and verified against existing methodologies.

- Machine learning
- Perioperative care
- Postoperative complications
- Fully assist AI

Related conference:

Related associations &societies:

International conference on obesity and weightless pills | international conference on obesity and metabolism (ICOM) | genetic obesity and bariatric surgery conference| world weight loss surgery association | German weight loss surgery group | neuroendocrinology and bariatric surgery conference | international conference on current trends in therapies for obesity |world obesity management association | world nutrition society | Brazilian society of nutrition | world childhood obesity management | genetic obesity association | international conference on current trends in therapies for obesity

Track 16: Metabolic and bariatric surgery

Metabolic-bariatric surgery results in significant weight loss and the prevention or alleviation of obesity-related hazards and consequences. More comprehensive estimates of its influence on long-term mortality and life expectancy, particularly stratified by pre-existing diabetes status, are needed, however, to inform policy and assist patient counseling. Metabolic and bariatric surgery (MBS) has been found to improve both liver steatohepatitis and fibrosis by causing considerable and persistent weight reduction. In the management of energy balance, the hypothalamus is the primary integrator of peripheral and central inputs. Its functional significance for the efficacy of bariatric surgery is not well understood. The consequences of bariatric surgery on individuals with hypothalamic impairment might give clues.

- Hypothalamic integrity
- Hypertension and bariatric surgery
- Hypertriglyceridemia
- Cardiovascular diseases

Related conference:

Balanced Diet And Nutrition Conference | Food Technology And Nutrition Conference 2023 | Obesity Conference 2023 |Bariatric Surgery Conference 2023 |Nutrition Conference 2023| Obesity And Bariatric Surgery Conference 2023| Food And Obesity Conference |Food Technology And Obesity Conference |Gastric Bypass And Obesity Conference |Balanced Diet And Obesity Conference| International Conference On Obesity And Metabolism (ICOM)| Artificial Intelligence In Bariatric Surgery Conference| Genetic Obesity And Bariatric Surgery Conference| Neuroendocrinology And Bariatric Surgery Conference| Metabolism, Obesity And Bariatric Surgery Conference| Artificial Intelligence In Bariatric Surgery Conference | Nutrition And Obesity Conference |World Childhood Obesity Management Conference | Nutrition And Weight Manage Conference

Related associations &societies:

Track 17: Bariatric surgery risks

As with any major procedure, bariatric surgery poses potential health risks, both within the short term and the long term. Bariatric surgery is regarded as an intermediate- to high-risk noncardiac surgery because of the significant medical comorbidities and procedure-related hazards that are associated with it.

The most remarkable effect of bariatric surgery is the complete and rapid remission of type 2 diabetes mellitus, a disease that was previously assumed to be irreversibly progressive and minimally responsive to therapies except for a few demanding and unrealistic protocols. Diabetes remains our most complex and costly disease, despite various medical advances. Diabetes, which is growing faster than any other chronic disease, now affects more than 24 million Americans and is the leading cause of blindness, renal failure, and amputations in the United States, as well as a major cause of heart disease and stroke.

Severe obesity affects almost every system of the human body, resulting in a wide range of serious diseases such as pseudotumor cerebri, hypertension, diabetes, renal failure, immunocompetence, asthma, gastroesophageal reflux disease, chronic obstructive pulmonary disease, cardiac failure, atherosclerosis, Pickwickian syndrome, arthritis of the weight-bearing joints, infertility, skin breakdown, and an increased prevalence of cancers, particularly colon, prostate, and breast cancer.

- Exocrine pancreatic insufficiency
- Hypertension remission
- Hypercholesterolemia remission
- Diabetes remission

Related conference:

Related associations &societies:

Endocrine and bariatric surgery conference| International conference on neuroendocrinology and obesity| Gastroenterology in bariatric surgery conference| Gastroenterology in bariatric surgery conference| Metabolic and bariatric surgery conference| metabolic and bariatric surgery conference| Advanced treatment for obesity in bariatric surgery conference |genetic obesity association | world obesity management association |healthy nutrition society | dietary therapy and bariatric surgery conference

Track 18: Impact of bariatric surgery on cancer

The results of registry-based population studies were evaluated in this study to determine the effect of bariatric surgery on cancer incidence at the population level. Pooled odds ratios (POR) for the occurrence of cancer following bariatric surgery compared to controls were calculated using a meta-analysis of relevant papers. Obesity is thought to be a risk factor for several forms of cancer, including colorectal cancer (CRC). Bariatric surgery has been linked to decreases in obesity-related co-morbidities as well as a total cancer risk. However, given the inconsistent results of various cohort studies, the influence of bariatric surgery on CRC risk appears to be debatable. Furthermore, CRC biomarker measurements after ROUX-EN-Y gastric bypass (RYGB) demonstrated hyperproliferation and elevated proinflammatory gene expression in the rectal mucosa. Alterations in the gut microbiota and exposure of the colorectum to high amounts of bile acids are postulated processes leading to increased CRC risk, both of which are produced by RYGB-induced anatomical rearrangements.

Obesity and cancer
Overall, cancer risk
Esophagogastric tumors
Gastric cancers
Colorectal and hormone-sensitive

Related conference:

Related associations and societies:

Track 19: Advanced treatments for obesity

Obesity is a major public health issue that has returned to epidemic proportions in the western world. Evidence continues to mount that obesity is a major risk factor for many diseases and is linked to substantial morbidity and mortality. Surgery on the stomach and intestines to assist someone who has lost a lot of weight quickly. People who have a body mass index above 40 may be candidates for bariatric surgery. Surgery is also an option for people with a body mass index of 35 to 40 who have health issues such as heart disease and type 2 diabetes.

In addition to a low-calorie diet and regular physical activity, nice presently recommend pharmaceutical treatment for weight reduction maintenance. Pharmacological alternatives are currently limited on the NHS, with the majority permitted for weight loss maintenance in patients with a BMI of >27 kg/m2 and associated risk factors, or those with a BMI of 30 kg/m2.

Endoscopic therapeutic devices for the treatment of obesity have been rapidly developed in recent years, either as adjuncts to bariatric surgery or as an alternative for individuals who may not be suitable surgical candidates, decline surgery due to the risks involved, or prefer a less invasive therapeutic strategy. Endoscopic therapeutic devices for the treatment of obesity have been rapidly developed in recent years, either as adjuncts to bariatric surgery or as an alternative for individuals who may not be suitable surgical candidates, decline surgery due to the risks involved, or prefer a less invasive therapeutic strategy.

Dietary therapy
Pharmacotherapy
Orlistat
Endoscopic interventions
Liraglutide

Related conference:

Anti-Aging Strategies And Bariatric Surgery Conference| Anti-Aging Strategies And Bariatric Surgery Conference | GERD SYMPTOMS In Bariatric Surgery Conference | Balanced Diet And Obesity Management Conference | Genetic Obesity And Balanced Diet Conference | Genetic Obesity Conference 2023 | Genetic Obesity Conference 2023 | Genetic Obesity Conference | Balanced Diet And Genetic Obesity Conference |Childhood Obesity And Gastric Bypass Conference | Nutrition And Obesity Conference | Ai In Bariatric Surgery Conference| Nutrition And Weight Manage Conference | Nutrition And Childhood Obesity Conference | Childhood Obesity And Genetic Obesity Conference | Gastric Bypass In Bariatric Surgery Conference

Related associations &societies:

Market Analysis

The rising incidence of chronic conditions like diabetes and obesity worldwide, as well as the increasing number of weight reduction procedures, are some of the primary drivers leading the bariatric surgery market revenue growth.

According to the national institutes of health, obesity and overweight are the 2nd largest causes of avoidable mortality in the United States, accounting for an estimated 300,000 deaths each year. Bariatric surgery is a successful therapy for extreme obesity, resulting in the improvement or remission of many obesity-related comorbid disorders as well as long-term weight loss.

According to emergent research, the global bariatric surgery market size was USD 2.41 billion in 2020 and is expected to reach USD 4.81 billion in 2028 and register a revenue CAGR of 9.0% during the forecast period, 2021-2028.

The rising prevalence of chronic diseases such as diabetes and obesity worldwide and increasing volumes of weight loss surgeries are some key factors driving the bariatric surgery market revenue growth.

By 2030, one billion people worldwide, including one in five women and one in seven men, will be obese, according to the world obesity atlas 2022, issued by the world obesity federation. Obesity is a condition that affects all of the body's systems. It has ramifications for the heart, liver, kidneys, joints, and reproductive system. It causes a variety of noncommunicable diseases (NCDs), including type 2 diabetes, cardiovascular disease, hypertension, and stroke, as well as many types of cancer and mental health difficulties. Obese people are also three times more likely to be hospitalized with covid-19.

Most obese countries in the world

According to the world health organization, there are now 1.6 billion overweight adults in the world. Based on the most recent data available from the world health organization, the island nation of Nauru has the highest rate of obesity in the world, with obesity affecting 61.0% of the adult population and the least obese nation in Vietnam.

Obesity management market outlook (2022-2032)

The obesity management market is estimated to increase at a 5.1% CAGR between 2022 and 2032, from USD 828.71 million to USD 1362.80 million. The obesity management industry is likely to create considerable revenue in the future due to the high growth in obesity prevalence over the previous two decades.

Procedure outlook

sleeve gastrectomy, gastric bypass, revision bariatric surgery, non-invasive bariatric surgery, adjustable gastric banding, mini-gastric bypass, and biliopancreatic diversion with duodenal switch (BPD/ds) are the procedures classified in the bariatric surgery devices market. The sleeve gastrectomy category will have the biggest revenue share of the bariatric surgical devices market in 2022. The increased popularity of sleeve gastrectomy can be attributed to the size of this market. When compared to other bariatric procedures, advantages include safety, efficacy, cost, and fewer complications.

bariatric surgery market, by end-users:

Ambulatory surgical centers
Bariatric surgery clinics
Hospital pharmacies

The market is divided into three end-user segments, bariatric surgery clinics, and hospital pharmacies. Bariatric surgery clinics have accounted for the greatest market share, accounting for up to 38% of the segment's market share. The growth can be ascribed to an increase in bariatric procedures worldwide. During the projection period, hospital pharmacies are also predicted to increase at a reasonable rate.

Major companies in the global bariatric surgery market include:

The global bariatric surgery devices market size is expected to reach $2.4 billion by 2028, rising at a market growth of 5.3% CAGR during the forecast period

Medtronic plc
Allergan inc.
B. Braun Melungeon ag
Johnson & Johnson
Olympus corporation
Apollo endo-surgery, inc.
Coned corporation
Intuitive surgical, inc.
Medi-flexes surgical procedures
Gi dynamics in

Past Conference Report

The International Obesity, Bariatric and Metabolic Surgery Summit and Expo which was recently held during August 23-24, 2017 at Holiday Inn Toronto International Airport, Toronto, Canada has received an overwhelming and immense participation from scientists, researchers, young researchers and foremost, the Editorial Members of Allied Academies Journals.

The conference was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 10 countries, who have driven this event into the path of success.

Bariatric Surgery 2017 Organizing Committee would like to thank the Moderators of the conference who contributed profoundly for the smooth functioning of this event:

Susan Brown, KentuckyOne Health, USA
Joycelyn M Peterson, Oakwood University, USA

The conference moved on with Keynote-presentations which remained as one of the highlights presented by:

Mervyn Deitel, MGB-OAGB Club, Canada

Joycelyn M Peterson, Oakwood University, USA

Bobby Whisnand, Bobby Whisnand Fitness, USA

Chandra Hassan, University of Illinois at Chicago, USA

The highlights of the meeting were the passionate lectures, delivered by Susan Brown, KentuckyOne Health, USA; Yoko Takahata, Baika Women’s University, Japan; Surendra Ugale, Asian Bariatrics Hospital, India; Emilian Rejane Marcon, Hospital de Clínicas de Porto Alegre, Brazil; César Antonio Martínez-Ortiz, National Autonomous University of Mexico School of Medicine, Mexico; Yannick Mandeville, AZ-Delta ziekenhuis, Belgium; Darline K El Reda, Kuwait University, Kuwait; Tasleem A Zafar, Kuwait University, Kuwait; Marjan Farshadi, Toronto Liver Centre, Canada; Shaweta Vasudeva, Aerobics and Fitness Association of America, USA; Qiaozhu Su, University Of Nebraska-Lincoln, USA. The pragmatic presentations were of great interest and have shed light on innovative projects and current arenas in Obesity and Bariatric Surgery.

The extremely dignified scientific sessions were much-admired with more keenness and enthusiasm filled contributions from doctors, scientists, researchers and principal investigators. Some of the conspicuous sessions were, but not alone, Obesity, Roux-en-Y gastric bypass, Gastric Plication Surgery, Intragastric Balloon, Adjustable Gastric Banding, Biliopancreatic diversion with duodenal switch, vBloc Therapy, Sleeve Gastrectomy, Anaesthesia and bariatric surgery, Management of weight regain after surgery, Nutrition after bariatric surgery, Bariatric Nursing.

Eminent speakers from various universities and organizations took part in the conference.

MGB-OAGB Club, Canada

Oakwood University, USA

Bobby Whisnand Fitness, USA

KentuckyOne Health, USA

Baika Women’s University, Japan

Benha University, Egypt

Asian Bariatrics Hospital, India Hospital de Clínicas de Porto Alegre, Brazil

National Autonomous University of Mexico School of Medicine, Mexico

AZ-Delta ziekenhuis, Belgium

University of Illinois at Chicago, USA

University of Montreal, Canada

University Faculty of Medicine, Turkey

Kuwait University, Kuwait

Toronto Liver Centre, Canada

Aerobics and Fitness Association of America, USA

University Of Nebraska-Lincoln, USA

We wish a Warm gratitude to our Endorsed Media partners, “New York Private Enquiry Forums, Andrew John Publishing Inc.” for associating with the conference.